__timestamp | Arrowhead Pharmaceuticals, Inc. | Bio-Techne Corporation |
---|---|---|
Wednesday, January 1, 2014 | 175000 | 251411000 |
Thursday, January 1, 2015 | 382000 | 307277000 |
Friday, January 1, 2016 | 158333 | 336659000 |
Sunday, January 1, 2017 | 31407709 | 374541000 |
Monday, January 1, 2018 | 16142321 | 432143000 |
Tuesday, January 1, 2019 | 168795577 | 473491000 |
Wednesday, January 1, 2020 | 87992066 | 483194000 |
Friday, January 1, 2021 | 138287000 | 632850000 |
Saturday, January 1, 2022 | 232810000 | 756496000 |
Sunday, January 1, 2023 | 240735000 | 769815000 |
Monday, January 1, 2024 | 3551000 | 769725000 |
In pursuit of knowledge
In the dynamic world of biotechnology, Bio-Techne Corporation and Arrowhead Pharmaceuticals, Inc. have carved distinct paths over the past decade. From 2014 to 2023, Bio-Techne's gross profit surged by over 200%, peaking at approximately $770 million in 2023. This growth underscores its robust market position and innovative prowess. In contrast, Arrowhead Pharmaceuticals, while starting with a modest gross profit of around $175,000 in 2014, experienced a meteoric rise, achieving a staggering 137,000% increase by 2023. This remarkable growth trajectory highlights Arrowhead's strategic advancements in RNA interference therapeutics. Despite the absence of 2024 data, these trends reflect the companies' resilience and adaptability in a competitive landscape. As the biotech sector continues to evolve, these two companies exemplify the potential for innovation-driven success.
Key Insights on Gross Profit: Pfizer Inc. vs Bio-Techne Corporation
Gross Profit Comparison: Biogen Inc. and Bio-Techne Corporation Trends
Key Insights on Gross Profit: Bio-Techne Corporation vs BioMarin Pharmaceutical Inc.
Bio-Techne Corporation and Jazz Pharmaceuticals plc: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Bio-Techne Corporation vs Amneal Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Bio-Techne Corporation and Perrigo Company plc
Annual Revenue Comparison: Bio-Techne Corporation vs Arrowhead Pharmaceuticals, Inc.
Key Insights on Gross Profit: Bio-Techne Corporation vs Ligand Pharmaceuticals Incorporated
Cost Management Insights: SG&A Expenses for Bio-Techne Corporation and Arrowhead Pharmaceuticals, Inc.
Gross Profit Comparison: Bio-Techne Corporation and Amphastar Pharmaceuticals, Inc. Trends
Who Generates Higher Gross Profit? Bio-Techne Corporation or Taro Pharmaceutical Industries Ltd.
Corcept Therapeutics Incorporated and Arrowhead Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis